Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

@inproceedings{Majeed2013ManagementAO,
  title={Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin},
  author={Ammar Majeed and Hun-Gyu Hwang and Stuart J. Connolly and John W. Eikelboom and Michael Ezekowitz and Lars Wallentin and Martina Brueckmann and Mandy Fraessdorf and Salim Yusuf and Sam Schulman},
  year={2013}
}
Coagulation Unit, Hematology Center, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden; Dept of Medicine, Soonchunhyang University Gumi’s Hospital, North Kyungsang Province, South Korea; McMaster University, Population Health Research Institute, Hamilton, ON, Canada; Lankenau Medical Center, Thomas Jefferson Medical College, Wynnewood, PA; Uppsala Clinical Research Center and Dept of Medical Sciences, Uppsala University, Uppsala, Sweden; Boehringer Ingelheim Pharma GmbH… CONTINUE READING